SHARE:

Organizational Disclosure

Below is a breakdown of industry contribution towards the consolidated revenue of the Academy (American Academy of Neurology and American Academy of Neurology Institute). Industry includes for-profit entities that develop, produce, market, or distribute drugs, devices, services, or therapies used to diagnose, treat, monitor, manage, and alleviate health conditions (e.g., pharmaceutical and medical device/software manufacturers and other for-profit health services/product providers). Industry does not include non-profit entities, entities outside of the healthcare sector, or entities through which physicians provide clinical services directly to patients (e.g., hospitals, medical centers, publishers, foundations, recruiters, insurance providers).

2016

  • Total Industry Revenue: $8,279,862
  • Percentage of Total Academy Revenue: 17%
  • Educational Grants: $594,904
  • Sponsorship: $4,082,298
  • Exhibit Space: $2,516,550
  • Charitable Contributions:  
  • Industry Roundtable Membership Dues : $770,000

Total contribution by company in 2016 (Greater than $100K):

  • Sanofi Genzyme
  • Genentech
  • Lundbeck
  • Novartis Pharmaceuticals
  • Biogen
  • Sunovion Pharmaceuticals Inc.
  • ACADIA Pharmaceuticals Inc.
  • Allergan, Inc.
  • AbbVie, Inc.
  • Teva CNS
  • Supernus Pharmaceuticals, Inc.
  • UCB, Inc
  • Bayer HealthCare
  • EMD Serono, Inc.
  • Eli Lilly and Company
  • Amgen
  • Upsher-Smith Laboratories, Inc.
  • Eisai Inc.
  • IMPAX Pharmaceuticals
  • Mallinckrodt Pharmaceuticals
  • Mylan Inc.
  • Medtronic, Inc.

View the Principles Governing Academy Relationships with External Sources of Support.

View the Council of Medical Specialty Societies Code for Interactions with Companies.

Related Content

MEMBER LOG IN

Forgot password?

**Due to required system maintenance on AAN.com, some functions may be unavailable Saturday from 1:00 p.m. to 6:00 p.m. Saturday (12/9/2017). Thank you for your patience.**

Advertisement
Advertisement